BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• 

  Joanna Smiley

  Joanna is an entrepreneur and award-winning journalist with over 20 years of writing experience that includes a niche expertise in technical science.
  
  
• 

  Business

  51%: The Untapped Market

  In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital Group discuss how critical it is to incorporate women into leadership positions and board rooms as a sound investment strategy.
  

  November 21, 2024

   · 

  1 min read

   · 

  Lori Ellis
• 

  GLP-1

  Lilly Partners With Chinese Biotech to Advance Muscle-Sparing Obesity Treatment

  Eli Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the activin type IIA receptor to induce weight loss and boost muscle mass.

  November 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Trends

  Flexing on the Competition? Smaller Companies Get Higher Marks for Flexibility

  Many biopharma professionals view smaller companies as having the best flexibility and remote work options, but that doesn’t mean their larger counterparts are failing in that area. Several professionals, including Apogee Therapeutics and Insmed executives, share their insights.

  November 21, 2024

   · 

  6 min read

   · 

  Angela Gabriel
• 

  Mergers & acquisitions

  Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030

  Novartis’ up to $1.1 billion acquisition of gene therapy specialist Kate Therapeutics fits with the pharma’s plan to expand its new modality pipeline to ensure long-term business sustainability.

  November 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & Acquisitions

  Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science

  Novartis has disclosed roughly $19.4 billion in deals in the past five years. CEO Vas Narasimhan says there’s more to come.

  November 21, 2024

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Government

  COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post

  Makary is a pancreatic surgeon at Johns Hopkins who became known for battling medical mistakes and in recent years has been an outspoken critic of COVID-19 policies.

  November 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Trends

  5 Biopharma Companies Hiring in New York

  Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.

  November 21, 2024

   · 

  1 min read

   · 

  Chantal Dresner
• 

  Cancer

  Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax

  The agreement will give Kura enough capital to support the development and launch of its menin inhibitor ziftomenib.

  November 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Creations

  Massachusetts Increases Life Sciences Investment by $500M Over 10 Years

  Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.

  November 21, 2024

   · 

  2 min read

   · 

  Angela Gabriel